Table 3. Comparison of clinical data of survivor and non-survivor patients.

 ⁕Significance at the 5% level; P value is a statistical measure that indicates whether or not an effect is statistically significant.

AKI; Acute Kidney Injury; KDIGO: Kidney Disease-Improving Global Outcomes; RIFLE: Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease

Variables	Survivors		Non Survivors		P value
Active smokers	Yes	No	Yes	No	N/A
Ex-smokers	23 (20.9%)	87 (79.1%)	2 (14.3%)	12 (85.7%)	0.562
Smokers	19 (17.3%)	100 (82.7%)	1 (7.1%)	13 (92.9%)	0.334
Hypertension	19 (17.3%)	100 (82.7%)	3 (21.4%)	11 (78.6%)	0.703
Diabetes	5 (4.5%)	105 (95.5%)	4 (28.6%)	10 (71.4%)	0.001*
Thyroid	9 (8.2%)	100 (91.8%)	1 (7.1%)	13 (92.9%)	0.893
AKI diagnosed with KDIGO	33 (30.0%)	77 (70.0%)	14 (100.0%)	0 (0.0%)	0.0001*
AKI diagnosed with RIFLE	10 (9.1%)	100 (90.9%)	9 (64.3%)	5 (35.7%)	0.0001*